Registration Info

This is a 1-day meeting and will provide 6 CE/CME credits.

Conference Registration Fee

Practicing Healthcare Professionals: $129

Register now >>

Non-Clinicians / Medical Office Support Staff / Industry Participants

In order to maintain the clinical nature of the conference, nonclinicians—including, but not limited to, office managers, billing specialists, receptionists, and administrative staff; guests, spouses, friends, and/or family members—may not attend PAINWeekEnd.

Venue

Unfortunately, we do not have discounts available on hotel rooms. Please contact the hotel directly should you require accommodations.

Renaissance Providence Downtown Hotel
5 Ave of the Arts
Providence, RI 02903

View hotel website >>

Directions

Get Directions using Google Maps

Agenda

Faculty and courses are subject to change. Please refer to the online agenda below for the most recent course descriptions.

To view the agenda below, click on the + sign next to the day of the conference to expand the conference agenda. Click on the + signs within the agenda to view the course description, UAN number, and AANP pharmacology credits.

*not certified for credit

Saturday, June 22, 2019

  • REGISTRATION AND EXHIBITS

    Coffee will be served.

  • Falling Down the Rabbit Hole: A Primer for Chronic Pain Management and Substance Abuse Disorders

    The field of pain management has undergone a circuitous adventure, much like a rabbit hole. As the economic, mental health, and medical consequences of prescribing opioid medications have mounted, the prevailing logic regarding the usefulness of prescribing opioids for chronic pain has shifted. The widespread dissemination of opiates and the lax safety measures placed on their storage has also led to an increase in nonmedical use. Given the high level of comorbidity between opioid use disorders and chronic pain, providers’ decisions about how to address treatment with patients who may have or who have been diagnosed with substance use disorders are often complex. The new CDC guidelines will require providers to assess for risk of overdose or development of a substance use disorder, and to be keenly aware of their patients’ pain levels and pain management strategies when working as part of a system where opioid medications may be prescribed. Participants will learn how patient and provider education programs and communication interventions may improve outcomes in pain management. Participants will also learn how to select candidates for opioid trials, assess for risk, and initiate opioid therapy, but only after exploring nonopioid and nonpharmacological strategies.

    • UAN: 0530-0000-19-055-L01-P
    • AANP Rx Hours: 0.00
  • PRODUCT, DISEASE AWARENESS, MEDICAL INFORMATION PROGRAM*

    Breakfast will be served.

    Sponsored by Legally Mine.

  • BREAK & EXHIBITS

  • 3's Company: COX-2 Inhibitors, Medicinal Marijuana, and Opioid Prescribing

    There is much controversy around many aspects of pain treatment, and compelling arguments have focused on both sides of the fence regarding appropriate opioid use and prescribing, legalization of marijuana, and the safety of cox-2 inhibitors. In all  3 cases, there are issues associated with strong positions, although the evidence, when put into practice, is less black and white. For each topic, we will evaluate current literature and debate the clinical, legal, and ethical controversies surrounding recent developments in pain management. Attendees will get a better understanding as presenters debate evidence based application of the cdc guidelines in various clinical settings, evaluate clinical and ethical concerns regarding marijuana for medicinal or recreational use, and take a critical look at the literature and its application when using cox-2 inhibitors for treating pain.

    • UAN: 0530-0000-19-050-L01-P
    • AANP Rx Hours: 0.00
  • No Guts No Glory: Mystery of the Microbiome

    In the age of modern medicine, it is easy to forget that we change our body chemistry every time we eat. The quality and composition of our food has the power to increase or decrease body wide inflammation and modulate pain. Our relationship to food and the way we eat is also cultural and influenced by stress and our environment. The research evidence is robust for dietary interventions and improved health. The changes needed are simple, but not necessarily easy.  This lecture will focus on the role that modulation of the microbiome plays in pain, and ways to optimize the health of the individuals’ gut microbes for pain management and overall wellbeing.

    • UAN: 0530-0000-19-036-L01-P
    • AANP Rx Hours: 0.00
  • FACULTY Q&A

  • BREAK & EXHIBITS

  • PRODUCT, DISEASE AWARENESS, MEDICAL INFORMATION PROGRAM*

    Lunch will be served.

    Sponsored by SCILEX.

  • Precise Prescribing: Applying the Science of Pain to Treatment Decisions

    There is a growing opioid epidemic and our role as providers and patient leaders in the community cannot be overstated. We need to recognize the growing burden of this problem as well as the role of all stakeholders in addressing the opioid epidemic in their communities. What is the prevalence, nationally and locally, for opioid use and prescribing? Where are the growing pockets and populations of opioid use? What is the Drug Enforcement Agency’s perspective from the front lines? In this course you learn how to apply knowledge of acute and chronic pain pathways and underlying mechanisms to clinical assessment and appropriate management of pain. Through the use of a 3D presentation, the differences between acute and chronic pain pathways and pain points and specific targets for opioids—appropriate and inappropriate—will be demonstrated. We will evaluate current clinical workflows for opioid prescribing, incorporating 2 best practice strategies to optimize safe and competent prescribing and minimize potential for abuse and diversion. Discussed will be working with patients to develop multimodal pain strategies; how to minimize the risk for diversion and abuse; and safe disposal of medications. After this course, you will be able to access resources and guidelines to recognize and treat patients with opioid use disorder and integrate into practice concepts from novel programs in the community to address opioid overdose and treat patients with opioid use disorder.

    Presented by CME Outfitters and USF Health. Supported by an educational grant from Johnson & Johnson.

    Click here to download the slides for this presentation.

    • UAN: 0376-0000-19-015-L01-P
    • AANP Rx Hours: Coming soon.
  • PRODUCT, DISEASE AWARENESS, MEDICAL INFORMATION PROGRAM*

    Refreshments will be served.

    Sponsored by Emergent BioSolutions.

  • The 411 on Nonprescription Analgesics: When to Hold ‘Em, When to Fold ‘Em

    Pain is the number one reason why patients seek advice from their pharmacist or primary care provider. Patients very often seek to use a nonprescription analgesic to self-treat a painful complaint, yet often do not understand the exclusions to self-treatment or how to select the best analgesic. Participants in this presentation will learn what nonprescription analgesics are available, indications for use, appropriate dosing and duration of therapy, appropriateness of candidates, and how to monitor and educate patients about their nonprescription analgesic. At this presentation, participants will learn the mechanism of action, indications, adverse effects, and precautions of oral and topical nonprescription analgesics, along with patient counseling points when recommending a nonprescription analgesic.

    • UAN: 0530-0000-19-051-L01-P
    • AANP Rx Hours: 0.70
  • Medical & Recreational Cannabis: What’s a Clinician to Do?

    The endocannabinoid system (ECS) is now recognized as an important modulator of many physiological processes. Even more recently, an increasing body of evidence has been accumulated to suggest the antioxidant, anti-inflammatory, neuroprotective, and antinociceptive roles of the ECS. In 1997, the Office of National Drug Control Policy commissioned the Institute of Medicine (IOM) to conduct a comprehensive study of the medical efficacy of cannabis therapeutics. The IOM concluded that cannabis is a safe and effective medicine, patients should have access, and the government should expand avenues for research and drug development. This course will discuss cannabis as it relates to effective pain management.

    • UAN: 0530-0000-19-034-L01-
    • AANP Rx Hours: 0.60

SPONSORED PROGRAMS

To accompany and enrich your experience at the PAINWeekEnd conference, be sure to attend one or more of the sponsored programs, which are scheduled during breakfast, lunch, and afternoon "Brain Food" time slots in the schedule. There is NO ADDITIONAL CHARGE to attend these program sessions!